Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Tuesday 6th February 2018 from 11.00am to 11.15am (GMT).

During this time our website performance may be temporarily affected. If you have any questions please use the feedback button available under our menu button. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 26, 2013
Previous Article Next Article

Conformationally restricted short peptides inhibit human islet amyloid polypeptide (hIAPP) fibrillization

Author affiliations

Abstract

hIAPP fibrillization implicated in Type 2 diabetes pathology involves formation of oligomers toxic to insulin producing pancreatic β-cells. We report design, synthesis, 3D structure and functional characterization of dehydrophenylalanine (ΔF) containing peptides which inhibit hIAPP fibrillization. The inhibitor protects β-cells from hIAPP induced toxicity.

Graphical abstract: Conformationally restricted short peptides inhibit human islet amyloid polypeptide (hIAPP) fibrillization

Back to tab navigation

Supplementary files

Publication details

The article was received on 16 Dec 2012, accepted on 11 Feb 2013 and first published on 13 Feb 2013


Article type: Communication
DOI: 10.1039/C3CC38982K
Citation: Chem. Commun., 2013,49, 2688-2690
  • Open access:
  •   Request permissions

    Conformationally restricted short peptides inhibit human islet amyloid polypeptide (hIAPP) fibrillization

    A. Mishra, A. Misra, T. Sri Vaishnavi, C. Thota, M. Gupta, S. Ramakumar and V. S. Chauhan, Chem. Commun., 2013, 49, 2688
    DOI: 10.1039/C3CC38982K

Search articles by author

Spotlight

Advertisements